Vaxcyte, Inc. — Director's Dealing 2024

Sep 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-09-03

Reporting Person: PICKERING GRANT (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-03	Common Stock	F	13669	$110.15	Disposed	465219	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	142130	Indirect
Common Stock	142130	Indirect

Footnotes

F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person.

F2: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's son.